Long-lasting gene therapy benefits advanced heart failure patients
Tuesday, November 19, 2013 - 11:00
in Health & Medicine
Researchers have reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients.